Examkin

Soru

Zorluk: ZorPharmacologic Interventions

Targeted antimicrobial therapy is being planned for a 62-year-old female currently receiving mechanical ventilation for severe pneumonia. She was transferred from a skilled nursing facility 3 days ago. Endotracheal aspirate cultures collected on admission have finalized, demonstrating heavy growth of methicillin-resistant Staphylococcus aureus (MRSA). The patient's past medical history is notable for major depressive disorder, generalized anxiety disorder, and osteoarthritis. Her routine home medications, which are currently being administered via an orogastric tube, include citalopram, buspirone, and scheduled acetaminophen. Current laboratory studies show a serum creatinine of 0.8 mg/dL and normal hepatic transaminases. Which of the following intravenous medications is the most appropriate targeted pharmacologic intervention for this patient?

  1. A
    Intravenous daptomycin
  2. B
    Intravenous meropenem
  3. Intravenous vancomycinCevap
  4. D
    Intravenous linezolid
  5. E
    Intravenous azithromycin

Cevap

Intravenous vancomycin is the correct medication because it effectively treats MRSA pneumonia without interacting with the patient's serotonergic medications.
Intravenous vancomycin is the correct choice because it provides reliable, standard-of-care coverage against MRSA pneumonia and lacks the specific contraindications associated with the other active agents in this clinical scenario. Since this patient has normal renal function, vancomycin can be safely administered with appropriate pharmacokinetic trough or AUC monitoring.

Adım Adım Çözüm

1
Identify the primary diagnosis and the isolated pathogen.
The patient has severe pneumonia with endotracheal cultures positive for MRSA.
Establishing the specific etiology and infection site is the required first step in selecting targeted antimicrobial therapy.
2
Consider site-specific contraindications for MRSA-active antibiotics.
Daptomycin must be excluded from consideration because it is irreversibly inactivated by pulmonary surfactant and is ineffective for pulmonary infections.
Antimicrobial efficacy depends on achieving therapeutic concentrations of the active drug at the actual site of infection.
3
Evaluate the patient's medication list for potential severe drug-drug interactions.
The patient is taking citalopram and buspirone, which increase serotonergic activity. Linezolid must therefore be avoided due to its MAOI activity and the high risk of serotonin syndrome.
Reviewing concurrent home medications prevents iatrogenic complications from overlapping pharmacodynamics.
4
Select the safest, most effective targeted agent from the remaining options.
Intravenous vancomycin is chosen as it covers MRSA, penetrates pulmonary tissue adequately, and lacks hazardous interactions with the patient's regimen.
Vancomycin represents the standard of care for MRSA pneumonia when linezolid is contraindicated.

Anahtar Kavram

Pharmacologic management of MRSA pneumonia requires navigating absolute contraindications, such as daptomycin inactivation by pulmonary surfactant, and severe drug interactions, such as linezolid coadministration with serotonergic agents.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru